Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Previous exposure to psychostimulants enhances the reinstatement of cocaine seeking by nucleus accumbens AMPA.
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist?
Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer.
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity.
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Bevacizumab
Child
Child, Preschool
Gestational Age
Humans
Intravitreal Injections
Laser Coagulation
Retinopathy of Prematurity
Retrospective Studies
authors with profiles
Michael Blair
Sarah Rodriguez